Publicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (51)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

  2. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica

  3. Highlights 57th SEPAR Congress

    Open Respiratory Archives, Vol. 6, Núm. 4

  4. Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses

    European Journal of Internal Medicine

  5. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2023

  1. Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 9, pp. 556-565

  2. First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

    Journal of Investigational Allergology and Clinical Immunology

  3. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a post hoc study of the ISAACC trial

    The European respiratory journal, Vol. 62, Núm. 6

  4. Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 193-195

  5. Is the long-term mortality similar in COVID-19 and community-acquired pneumonia?

    Frontiers in Medicine, Vol. 10

  6. Obstructive sleep apnoea is related to melanoma aggressiveness through paraspeckle protein-1 upregulation

    The European respiratory journal, Vol. 61, Núm. 2

  7. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

  8. Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 19-26

2022

  1. Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial

    Thrombosis Journal, Vol. 20, Núm. 1

  2. Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283

  3. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

  4. Real Life With Tezacaftor and Ivacaftor in Adult Patients With Cystic Fibrosis: Spanish Multicenter Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 672-674

2021

  1. A Web-based Application for Spirometry Quality in a Public Health System. 10 Year Follow Up

    Archivos de Bronconeumologia, Vol. 57, Núm. 11, pp. 724-725

  2. Association of the CFTR gene with asthma and airway mucus hypersecretion

    PLoS ONE, Vol. 16, Núm. 6 June

  3. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285